Cough syrup's dangers debated

Article

Baltimore's commissioner of health Joshua Sharfstein, MD, led a group of 16 senior pediatricians to petition the FDA regarding over-the-counter cough and cold remedies.

Many such OTC drugs have not been accurately tested on children for proper dosage. Four Baltimore children under the age of 4 who died were linked to unintentional overdoes in the last few years, and such overdoses also led to 900 hospitalizations throughout Maryland.

FDA's Office of Nonprescription Products responded with a conference call saying the OTC products were currently under investigation, with possible new dosage labeling to come. A statement from the Consumer Healthcare Products Association emphasized that, despite pictures of babies on the boxes, all such OTC drugs also say to contact a doctor for dosage instructions for children under 2.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
© 2025 MJH Life Sciences

All rights reserved.